Royal Bank Of Canada Issues Positive Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its price target increased by research analysts at Royal Bank Of Canada from $435.00 to $496.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target suggests a potential upside of 13.92% from the stock’s previous close.

A number of other research firms have also issued reports on HCA. BMO Capital Markets assumed coverage on HCA Healthcare in a report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 target price on the stock. Truist Financial dropped their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Barclays lowered their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. UBS Group lowered their target price on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Finally, Mizuho decreased their price target on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a report on Tuesday, July 28th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $466.35.

HCA Healthcare Trading Up 0.7%

Shares of NYSE:HCA opened at $435.38 on Wednesday. The stock has a market capitalization of $94.26 billion, a PE ratio of 14.59, a P/E/G ratio of 1.47 and a beta of 1.10. The firm has a fifty day moving average price of $418.32 and a 200 day moving average price of $420.54. HCA Healthcare has a 1 year low of $353.99 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.84 EPS. On average, sell-side analysts forecast that HCA Healthcare will post 29.42 earnings per share for the current fiscal year.

Institutional Investors Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in HCA. MidFirst Bank bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $28,000. Clearstead Trust LLC bought a new position in HCA Healthcare in the second quarter valued at approximately $29,000. Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $33,000. Delos Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the second quarter valued at $35,000. Finally, Merkkuri Wealth Advisors LLC acquired a new stake in HCA Healthcare in the first quarter valued at $43,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.